Searched for
NEURO ANALYSIS
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsFor the next few weeks, what needs to be watched is market breadth. And also look at which sectors are leading the rally. Why? Because, at ...
- Cardiac drugs log highest sales in 2025 as NCD cases surgeHeart medicines led sales in 2025, a trend set to continue. Respiratory and anti-diabetes drugs followed. Cardiac drug sales grew 13%, with...
- TV retains edge among affluent India as brand equity slips for FMCG majorsDespite a growing affluent consumer base, large FMCG brands face declining penetration and volume share in India. A Kantar study underlines...
- Companies worldwide are benefiting from embracing neurodiversity. Indian offices must followNeurodiversity is a popular term describing the fact that there are many variations of human functionality, and each variation needs to be ...
- India Inc embracing neurodiversity at workplaceCorporate India promotes neurodiversity by hiring individuals with autism, dyslexia and ADHD. Companies like SAP, EY, Publicis Sapient, Acc...
- Paediatric health startup Butterfly Learnings raises Rs 32 crore led by InsitorButterfly Learnings plans to use the funds to “extend its reach across multiple states and cities in India through a 200-center network,” i...
- PMLA: Jet Airways founder Naresh Goyal seeks interim bail to treat 'slow growing cancer'Jet Airways founder Naresh Goyal, facing charges in a money laundering case, has filed a plea for interim bail citing the need for treatmen...
- Neurological healthcare startup In-Med Prognostics raises $2.13 million in funding led by ExxoraFounded in 2018, In-Med Prognostics provides neuro analysis that aids in the assessment and early detection of neurological disorders such ...
- New drug RLF-100 shows dramatic recovery in COVID-19 patients suffering respiratory failureAviptadil is a formulation of Vasoactive Intestinal Polypeptide (VIP), which is present in high concentrations in the lungs and known to bl...
- AIIMS finds high toxin levels in 16% of patientsOf 216 patients tested, 32 (16%) had high levels of dangerous metals and substances, including arsenic, lead, chromium, fluoride, iron and ...
- Assess, Affirm, Apply, AlleviateThe simplicity of Functional Manual Therapy® is what allows creative solutions to every type of dysfunction and mobility issue at VARDAN.
- Naturopathy, Yoga, Ayurveda qualify as health care, exempt from GSTThe Centre has said that it has in-house pharmacy from where Ayurvedic products are dispensed for treatment and everyday treatment and foll...
- Pollution can permanently damage a child's brain: UnicefThe findings come at a time when India, particularly in the north, is facing a serious crisis due to rising levels of pollution. Last month...
- MNCs embrace autistic people to improve diversityJPMorgan has hired people with autism in roles for application and software development, quality analysis and business analysis, playing to...
- Industry-funded research plays down risk from mobiles: StudyAIIMS research shows studies with higher quality score show a trend towards harm, while lower quality score studies show a trend towards pr...
- UP man comes to the rescue of paralysed US manAn US research team headed by an Indian scientist has developed a technology that lets him control his limbs using just his “thoughts“.
- Study says loss of retina cells could be early sign of FTD in patients with genetic riskA new study has discovered that the loss of retina cells could be one of the earliest signs of FTD in patients with a genetic risk for the ...
- Drugs likely to cost more after hike in excise dutyDrugs are expected to cost more due to hike in excise duty to 6% from 5% on formulations and to 12% from 10% on bulk drugs announced by FM ...
- Nielsen betting big & bold on Indian marketFor global market research giant Nielsen, the centre of gravity is clearly shifting to India.
Load More
